Stanley Estime, MSCI December 9, 2014 Record Keeping: What is Regulatory Documentation and how should it be maintained? Tel: 617-432-2164

Slides:



Advertisements
Similar presentations
CROMS NIDCR Clinical Monitoring
Advertisements

Tips to a Successful Monitoring Visit
The Principal Investigator’s Roles and Responsibilities Chicken Soup for the Busy Coordinator (May 2010)
Content of Regulatory/Study Binder Human Subject Protection Office UConn Health Center Monika Haugstetter, MHA, RN, MSN & HSPO/IRB Staff.
Research Study Regulatory Binder Ronald Cowan, MD, PhD J. Gavin Lillevig, BS Summer Professional Didactics Data Management Psychiatric Neuroimaging Program.
Managing Regulatory Documents Electronically
Common Mistakes & Audits 05/21/2014. Summary of audit findings by category.
Audit Ebru Mutlu-Omega CRO. General Purpose to help quality (to maintain quality at present) to assure quality (make sure that quality in future is maintained)
Good Clinical Practice in Research
Recently Issued OHRP Documents: Guidance on Subject Withdrawal and Draft Revised FWA Secretary’s Advisory Committee on Human Research Protections October.
GCP compliance for GenISIS  This presentation is intended for clinical staff involved in recruiting patients to the GenISIS (Genetics of Influenza Susceptibility.
Developed by Klinikos; Roy Fraser (2012) Investigator Study File
John Naim, PhD Director Clinical Trials Research Unit
IRB 101: Introduction to Human Subject Research
IRB and Regulatory Documentation
Overview of Good Clinical Practices (GCPs)
The Ten Most Common Mistakes in IRB Submissions (How to avoid “3-tylenol-days”)
“So You Think You Know GCP …” Session S794 Jill Matzat, RN, BSN, CCRA, CCRT President, Medical Research Management & CRA Solutions, Inc. Paul Below, CCRA,
Regulatory Authority Governing Clinical Trials Anthony J. Minisi, MD Director, Cardiology Fellowship Program.
Role of the Oncology Research Team Carmen B. Jacobs, RN, OCN, CCRP.
RESCUE: ACRIN 4701 Protocol Development & Regulatory Compliance (PDRC) Josephine Schloesser, ACRIN Monitor Chris Steward, ACRIN QC Auditor.
Joint Research & Enterprise Office Training The team, the procedures, the monitor and the Sponsor Lucy H H Parker Clinical Research Governance Manager.
University of Miami Office of Research Compliance Assessment Lynn E. Smith, JD, CIM, CIP Johanna Stamates, RN, BA, CCRC With assistance from Elizabeth.
Research Auditing Presented by: Darlene Krueger, MBA RN CCRA Chief, GCP Auditing & Training VA Cooperative Studies Program Albuquerque, NM.
Monitoring IRB Monitoring of Clinical Trials. Types of Monitoring Internally Internally Externally Externally.
The QA/QI Process Human Research Subjects Protection Human Investigation Committee Tracy Rightmer, JD, CIP Compliance Manager.
CLINICAL TRIALS – PHASE III. What are phase III trials  Confirmatory phase (Therapeutic confirmatory trial)  Trials are done to obtain sufficient evidence.
Alyssa Speier, MS, CIP QA/QI Education Specialist Stanley Estime, MSCI QA/QI Specialist Interview, Survey, and Focus Group Research: IRB Processes and.
UC DAVIS OFFICE OF RESEARCH Overview of Good Clinical Practices (GCP) Investigator and Study Team Responsibilities Miles McFann IRB Administration Training.
Essential Documents and Regulatory Files Lack of planning can constitute an emergency Rachel Sheppard Regulatory Director, OCRSS.
Changes Afloat at the Harvard LMA IRB: what you need to know for smooth sailing.
Leslie Howes, MPH, CIP Alyssa Speier, MS, CIP September 24, 2014 Investigator Manual: ra/investigator-manual/
Human Subjects Research Office of Responsible Research Practices Human Subjects Research Vanessa Hill, MSHS, CCRC Senior Quality Improvement Specialist.
Stanley Estime, MSCI October 19, 2015 Record Keeping: What is Regulatory Documentation and how should it be maintained? Tel:
RIHES-II: H ANDLING A UDITS AND I NSPECTIONS E FFECTIVE D ATE 25 D ECEMBER 2006 V ERSION : 3.0 บุญเหลือ พรึงลำภู 15 มกราคม 2557.
Office of Human Research Protection Georgia Health Sciences University.
RIHES JJ: Required Training Version 7.0 Effective Date 27 JAN 2011 Boonlure Pruenglampoo 15 Jan 2014 วันพุธที่ 15 มกราคม พ. ศ 2557 RIHES-JJ Version 7.0.
Paul Hryvniak MS, CIP Alyssa Speier, MS, CIP September 30, 2014 Student Human Research Education Session Tel:
Sponsor Visits and Monitoring
Data Management – Regulatory Binder By: Johanna Park
CONDUCTING COMPLIANCE ASSESSMENTS Allen Ditch Director Corporate Quality Bristol Myers Squibb Medical Research Summit March 6, 2003.
Stanley Estime, MSCI QA/QI Specialist January 17, 2013 Reportable New Information.
Lifespan GOOD CLINICAL PRACTICE Record Management GCP May 2005.
Good Clinical Practices and Best Research Practices at MU Health Betty Wilson, CIP, MS Senior Compliance Manager MU IRB Lori Wilcox, EdD Director of Academic.
Session 2 IRB Training  What is the Principal Investigator’s role in Human Subject Research?  What is the role of the Investigator’s staff in Human Subject.
GCP (GOOD CLINICAL PRACTISE)
Slide 1 Standard Operating Procedures. Slide 2 Goal To review the standard operating procedures Creating the informed consent document Obtaining informed.
Responsibilities of Sponsor, Investigator and Monitor
Sponsor Visits and Monitoring Barbara Gallagher, RN Clinical Research Nurse Jefferson Clinical Research Institute.
The Role and Responsibilities of the Clinical Research Coordinator
Stephanie Oppenheimer, MS SUCCESS Center Erica Ellington, CRA, CHRC
Responsibilities of Sponsor, Investigator and Monitor
MAINTAINING THE INVESTIGATOR’S SITE FILE
Investigator of Record – Definition
Data Management – Regulatory Binder
Reportable Events & Other IRB Updates February 2017
Alyssa Speier, MS, CIP November 13, 2013
REDCap Regulatory Binder
Regulatory Binder: Maintaining Essential Study Documentation
Elements of an Organized Regulatory Binder
Basics of Building and Understanding Data Collection Forms
What Every Harvard LMA Student Investigator Should Know
Investigator of Record – Definition
Investigator of Record – Definition
CONDUCTING THE TRIAL AT
What Every Harvard LMA Student Investigator Should Know
MAINTAINING THE INVESTIGATOR’S STUDY FILE
CTSA27 So you want COMIRB to be your sIRB: What you need to know.
Senior Research Compliance Auditor
Good clinical practice
Presentation transcript:

Stanley Estime, MSCI December 9, 2014 Record Keeping: What is Regulatory Documentation and how should it be maintained? Tel: URL:

2 Today’s Agenda QIP Regulatory Binder – Review of Contents/Sections Tips for Successful Record Keeping QIPs New Electronic Record Keeping Applications: eRegulatory Binder (REDCap & eBox (Box.Com)

3 QIP Regulatory Binder Based on GCP list of Essential Documents and OHRA’s Recordkeeping/Record Retention requirements Provides a template for maintaining and organizing documentation to ensure compliance with federal regulations, institutional policies and good clinical practice – Alternatives exist: You can create your own way of organizing these documents that works best for you and your study team just BE CONSISTENT QIP provides record keeping recommendations and a regulatory binder based on best practices A study specific Binder will be provided based on the type of research being conducted (e.g., Social Behavioral, Biomedical, or FDA)

4 Binder Sections Overview (Essential Documents) Study-Specific: Lab Documents FDA Investigational Brochure Drug/Device Financial Disclosure NIH Sponsor DSMB Local Review All Studies: Protocol Staff CVs Staff Licensures Logs IRB Documents Consent Forms Data Collection Training

5 Essential Documents (All Studies) SectionPurposeConsiderations/ Recommendations ProtocolDemonstrates investigator and/or sponsor agreement to the protocol. Highlights current study objectives and procedures. Ensure that the version number/date reflects the current protocol. CVs and licensures Confirms staff qualifications to conduct a study or perform delegated tasks. CVs and licenses should be updated every 2 years to confirm that the information is accurate and current. Staff should sign and date CVs Maintain licensures for staff conducting clinically study related procedures

6 Essential Documents (All Studies) SectionPurposeConsiderations/ Recommendations LogsAssists with the collection of data that is required by or reported to the IRB or other regulatory authorities (e.g., Staff Delegation of Responsibility Log) Information in logs can be customized to fit a specific study or added to existing electronic versions currently maintained on site. IRB Documents Demonstrates that the IRB have reviewed and approved the study prior to initiation and continuing review, protocol modifications and reportable new information is communicated to the IRB. File correspondences for a given submission in reverse chronological order to ensure an accurate timeline from study start-up to completion. Keep submissions, requires modifications, investigator’s response and approvals together.

7 Essential Documents (All Studies) SectionPurposeConsiderations Informed ConsentDocuments that information is given to participants that support their ability to give informed consent. Maintains original copies of all IRB approved consent forms. Ensure that staff obtaining consent is using the most recently approved consent form. Data CollectionMaintains original copies of all forms used to collect study data (e.g., case report forms or questionnaires/ surveys). Only blank copies of forms should be kept in regulatory file. Participant files should be maintained separately in participant binder.

8 Essential Documents (All Studies) SectionPurposeConsiderations TrainingDocuments adequate training for all IRB approved personnel (e.g., CITI, protocol specific or sponsor training). Maintains documentation of all training records and certifications. Any HSPH affiliate working directly with human subjects’ data or tissue or has access to identifiable information must fulfill CITI training requirements every 3 years. Sponsor training requirements and timeframes may vary.

9 Study-Specific Documents Tissue/blood Specimens Laboratory Documents (e.g. - Director’s CV, Lab Normals and Certifications) Drug/Device FDA 1572 (drug) or Investigator Agreement (device) Investigational Brochure (drug) or Device Manual (device) Drug/Device Accountability IND/IDE Application Sponsored Financial Disclosures/Agreements NIH grant application & progress report Data Monitoring DSMB Charter and Reports External Review Local Ethical Approval Notice (external IRB, ERB or CAB)

OHRA Record Retention Policy Maintain documentation at least 7 years from study closure date Check with sponsor to ensure compliance with their record retention policies 10

Tips for Successful Record Keeping Address and resolve documentation problems immediately Review documentation routinely Document and update materials in real time 11

12 Tips, continued… Electronic Recordkeeping Maintain signed and dated note-to-file indicating the location of electronic correspondences. Ensure that electronic copies are available to study staff and regulatory authorities. Maintain copies of documents and correspondences with the original signatures (pdf).

REDCAP - eBinderBox.Com – eBox Binder Server basedCloud based Access to Data DictionaryUser-friendly UI CustomizableAssign task & reminders Single sign-on (Novell) iOS, WebOS, Android Highlights of Each Electronic Binder Platform 13

Demonstration of Key functions of eBinder(s) Storing Sharing Searching 14

Questions?  Leslie Howes, OHRA Director  QA/QI Specialists  Stanley Estime  Lisa Gabel  Alyssa Speier  OHRA:  See OHRA web site for department-assigned IRB Review Specialist and contact information 15